Free Trial

Sone Capital Management LLC Takes Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background

Sone Capital Management LLC purchased a new stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 129,412 shares of the company's stock, valued at approximately $8,303,000.

A number of other large investors also recently bought and sold shares of RYAN. Waters Parkerson & CO. LLC boosted its position in Ryan Specialty by 9.9% during the fourth quarter. Waters Parkerson & CO. LLC now owns 358,710 shares of the company's stock worth $23,015,000 after acquiring an additional 32,380 shares during the last quarter. Two Sigma Advisers LP lifted its stake in Ryan Specialty by 693.3% in the 4th quarter. Two Sigma Advisers LP now owns 35,700 shares of the company's stock worth $2,291,000 after purchasing an additional 31,200 shares in the last quarter. Two Sigma Investments LP boosted its holdings in shares of Ryan Specialty by 114.9% during the 4th quarter. Two Sigma Investments LP now owns 204,817 shares of the company's stock worth $13,141,000 after purchasing an additional 109,522 shares during the last quarter. ProShare Advisors LLC boosted its holdings in shares of Ryan Specialty by 11.6% during the 4th quarter. ProShare Advisors LLC now owns 4,979 shares of the company's stock worth $319,000 after purchasing an additional 519 shares during the last quarter. Finally, Quantinno Capital Management LP grew its position in shares of Ryan Specialty by 5.9% in the fourth quarter. Quantinno Capital Management LP now owns 14,163 shares of the company's stock valued at $909,000 after purchasing an additional 783 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.

Ryan Specialty Stock Up 1.1%

Shares of NYSE RYAN opened at $70.67 on Monday. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The business's 50 day moving average is $70.16 and its two-hundred day moving average is $68.75. Ryan Specialty Holdings, Inc. has a 52-week low of $52.34 and a 52-week high of $77.16. The firm has a market cap of $18.55 billion, a price-to-earnings ratio of 102.42, a PEG ratio of 1.19 and a beta of 0.68.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.39. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The company had revenue of $690.17 million for the quarter, compared to analyst estimates of $680.80 million. During the same period in the prior year, the firm earned $0.35 earnings per share. The business's revenue for the quarter was up 25.0% compared to the same quarter last year. Research analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Tuesday, May 13th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.68%. Ryan Specialty's payout ratio is currently 141.18%.

Wall Street Analysts Forecast Growth

RYAN has been the topic of a number of recent research reports. The Goldman Sachs Group raised Ryan Specialty from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $74.00 to $81.00 in a research note on Tuesday, May 13th. UBS Group boosted their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Royal Bank of Canada dropped their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a report on Friday, February 21st. TD Cowen assumed coverage on shares of Ryan Specialty in a research note on Thursday, April 10th. They set a "buy" rating and a $89.00 target price on the stock. Finally, Barclays decreased their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a report on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $76.42.

Read Our Latest Report on Ryan Specialty

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 11.10% of the company's stock.

About Ryan Specialty

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Further Reading

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines